One previous study showed that the non-toxic HSP inducer geranylgeranylacetone (GGA), a nontoxic antiulcer drug and inducer of small HSPs can inhibit desmin-related cardiomyopathy progression (Sanbe et al., 2009). Here, DES is linked to cardiomyopathy.